Astal Laboratories Ltd Financials
Company Logo

Astal Laboratories Ltd Financial Statement

Astal Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue25.38
Operating Expense22.17
Net Profit2.09
Net Profit Margin8.23
Earning Per Share2.13
EBIDTA2.97
Effective Tax Rate14.33

Astal Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual64.23
Operating Expenses Annual51.45
Operating Profit Annual12.90
Interest Annual0.70
Depreciation0.22
Net Profit Annual8.93
Tax Annual3.05

Astal Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning6.08
Cash Flow from Operations-12.52
Cash Flow from Investing-7.81
Cash Flow from Financing3.29
Cash Flow at the End-10.96

Astal Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)4.78
PBIT Margin (%)4.65
PBT Margin (%)-456.24
Net PROFIT Margin (%)3.30
Return On Networth / Equity (%)5.47
Return On Networth /Employed (%)7.56
Return On Assets (%)5.41
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)1.64

Astal Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual11.44
Total Current Assets Annual45.64
Non Current Assets Annual17.70
Total Shareholders Funds Annual35.99
Total Assets Annual63.34

Astal Laboratories Ltd Earning Calls

No Data Availabe

FAQS on Astal Laboratories Ltd Financials

As of Sep 6, 2025, Astal Laboratories Ltd has a market capitalization of 134.08 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Astal Laboratories Ltd is with a debt-to-equity ratio of 0.37.

In FY 2024 , Astal Laboratories Ltd recorded a total revenue of approximately 64.23 Cr marking a significant milestone in the company's financial performance.

Astal Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 1.2% and 1.5% annually, respectively..

Astal Laboratories Ltd's current PE ratio is 15.01.

Astal Laboratories Ltd's ROCE averaged 10.3% from the FY ending March 2023 to 2025, with a median of 4.6%. It peaked at 25.7% in March 2025, reflecting strong capital efficiency over the period..

Astal Laboratories Ltd's latest EBIT is Rs. 12.68 Cr, surpassing the average EBIT of Rs. 4.60 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions